Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
CMS Survey of 340B Drug Prices Garners Hospital Pushback
As reported initially by FierceHealthcare, hospitals are blasting the Trump administration’s move to survey them about drugs…
HHS and FDA Unveil Proposed Rules on Drug Importations
On December 18, 2019, the United States Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA)…
Humira and Lyrica Top List of Drugs with Steep Price Hikes
The Institute for Clinical and Economic Review (“ICER”) recently released a revised study entitled Unsupported Price Increase…
Generic Pharmaceutical Company Admits to Price Fixing
The Antitrust Division of the United States Department of Justice (DOJ) recently announced that a generic pharmaceutical company,…
CMS Administrator Seema Verma Criticizes High Drug Launch Prices
At the recent Milken Institute’s Future of Health Summit in Washington, DC, Centers for Medicare and Medicaid Services (“CMS”)…
Numerous State Laws and Pending Bills Intended to Address Rising Drug…
While the federal government continues to debate various policies for lowering prescription drug prices, many states have already…
US House HELP Committee Debates Pelosi’s Drug Pricing Bill
Recently, the House Health, Employment, Labor and Pensions (“HELP”) Subcommittee held a hearing to consider testimony and discuss…
California Releases Prescription Drug WAC Increase Data
The California Office of Statewide Health Planning and Development (“OSHPD”) recently released a report detailing mandatory…
How Are Insurers Treating the $2M Drug, Zolgensma?
It has been several months since the United States Food and Drug Administration (FDA) approved Novartis’ gene therapy drug…
Nevada Fines Drug Manufacturers for Failure to Comply with Drug…
In early October 2019, the Nevada Department of Health and Human Services sent letters to and levied more than $17 million in…